EB613, the first oral anabolic (bone building) peptide tablet for postmenopausal women with osteoporosis - FDA Type A endpoint alignment in July 2025, Phase 3 protocol submitted to the FDA with commen ...
A New Jersey man was arrested on Thursday after authorities said they foiled his plan to firebomb the home of a prominent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results